**Core Concept**
GPIIb/IIIa inhibitors are a class of anticoagulant drugs that target the glycoprotein IIb/IIIa receptor on platelet membranes. This receptor plays a crucial role in platelet aggregation, and by inhibiting it, GPIIb/IIIa inhibitors prevent the formation of a platelet plug.

**Why the Correct Answer is Right**
The correct answer is a drug that specifically binds to the GPIIb/IIIa receptor, blocking its ability to bind fibrinogen and other ligands. This results in a reduction in platelet aggregation and a decrease in the formation of thrombi. Examples of GPIIb/IIIa inhibitors include abciximab, tirofiban, and eptifibatide.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specifically target the GPIIb/IIIa receptor.
* **Option B:** This option is incorrect because it is not a GPIIb/IIIa inhibitor. Instead, it is an antiplatelet agent that works through a different mechanism.
* **Option D:** This option is incorrect because it is not a GPIIb/IIIa inhibitor. It may be a different type of anticoagulant or antiplatelet agent.

**Clinical Pearl / High-Yield Fact**
GPIIb/IIIa inhibitors are typically used in acute coronary syndromes, such as ST-elevation myocardial infarction, to prevent platelet aggregation and reduce the risk of thrombotic complications.

**Correct Answer: C. Eptifibatide**